Shopping Cart
Remove All
Your shopping cart is currently empty
MC-1-F2 is a direct FOXC2 inhibitor with anticancer activity, inhibits cancer stem cell (CSC) characteristics, and reduces the invasive ability of castration-resistant prostate cancer (CRPC) cell lines. MC-1-F2 can be used to study prostate cancer.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $256 | In Stock | In Stock | |
| 5 mg | $629 | In Stock | In Stock | |
| 10 mg | $892 | In Stock | In Stock | |
| 25 mg | $1,480 | In Stock | In Stock | |
| 50 mg | $1,970 | In Stock | In Stock | |
| 100 mg | $2,480 | In Stock | In Stock |
| Description | MC-1-F2 is a direct FOXC2 inhibitor with anticancer activity, inhibits cancer stem cell (CSC) characteristics, and reduces the invasive ability of castration-resistant prostate cancer (CRPC) cell lines. MC-1-F2 can be used to study prostate cancer. |
| In vitro | In PC3 or DU145 cell lines after treatment with DMSO (D), MC-1-F2 (F2, 20 µM) or MC-C2 (C, 20 µM) for 48 hours. A clear decrease in FOXC2 protein level upon 48-hour treatment with MC-1-F2. [1] |
| Molecular Weight | 746.87 |
| Formula | C37H46N16O2 |
| Cas No. | 2376894-10-7 |
| Smiles | N=C(N)NCCCCNC1=NC(=NC(=N1)N2CCN(C=3N=C(N=C(N3)NC4=CC=C(C=C4)N5CCOCC5)N)CC2)NC6=CC=C(OC=7C=CC=CC7)C=C6 |
| Color | Yellow |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (107.11 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (4.42 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.